Translocated microbiome composition determines immunological outcome in treated HIV infection
Translocated microbiome composition determines immunological outcome in treated HIV infectionLongitudinal high-dimensional analysis of translocated microbial products in the plasma of HIV+ individuals treated with combined antiretroviral therapy reveals dynamic changes in plasma cytokines and immune cell subsets, resulting in two distinct waves of immune reconstitution that lead to CD4+ T cell recovery.Longitudinal high-dimensional analysis of translocated microbial products in the plasma of HIV+ individuals treated with combined antiretroviral therapy reveals dynamic changes in plasma cytokines and immune cell subsets, resulting in two distinct waves of immune reconstitution that lead to CD4+ T cell recovery.Krystelle Nganou-Makamdop, Aarthi Talla, Ashish Arunkumar Sharma, Sam Darko, Amy Ransier, Farida Laboune, Jeffrey G. Chipman, Gregory J. Beilman, Torfi Hoskuldsson, Slim Fourati, Thomas E. Schmidt, Sahaana Arumugam, Noemia S. Lima, Damee Moon, Samuel Callisto, Jordan Schoephoerster, Jeffery Tomalka, Peter Mugyenyi, Francis Ssali, Proscovia Muloma, Patrick Ssengendo, Ana R. Leda, Ryan K. Cheu, Jacob K. Flynn, Antigoni Morou, Elsa Brunet-Ratnasingham, Benigno Rodriguez, Michael M. Lederman, Daniel E. Kaufmann, Nichole R. Klatt, Cissy Kityo, Jason M. Brenchley, Timothy W. Schacker, Rafick P. Sekaly, Daniel C. Douekhttps://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900653-X%3Frss%3Dyes&rc=0http://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignJuly 8, 2021
Powered by WPeMatico